Spinal anesthesia for cesarean delivery in a patient receiving fondaparinux
- PMID: 21603340
- PMCID: PMC3096169
Spinal anesthesia for cesarean delivery in a patient receiving fondaparinux
Abstract
Fondaparinux sodium, a selective inhibitor of factor Xa, is a new anticoagulant being used for thromboprophylaxis in all patient populations. We outline a case of neuraxial anesthesia for cesarean delivery in a patient with recent fondaparinux use and discuss most recent literature recommendations.
Keywords: Cesarean delivery; fondaparinux; neuraxial anesthesia; spinal.
References
-
- Ekbatani A., Asaro L. R., Malinow A. M. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia. Int J Obstet Anesth. 2010;19((1)):82–87. - PubMed
-
- Gerhardt A., Zotz R. B., Stockschlaeder M., Scharf R. E. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Thromb Haemost. 2007;97((3)):496–497. - PubMed
-
- Turpie A. G. Use of selective factor Xa inhibitors in special populations. Am J Orthop (Belle Mead NJ) 2002;31((11)(suppl)):11–15. - PubMed
-
- Turpie A. G., Eriksson B. I., Lassen M. R., Bauer K. A. Fondaparinux, the first selective factor Xa inhibitor. Curr Opin Hematol. 2003;10((5)):327–332. - PubMed
-
- Aiono-Le Tagaloa L., Carvalho B. Epidural labor analgesia in a patient receiving fondaparinux. Int J Obstet Anesth. 2009;18((1)):94–95. - PubMed
LinkOut - more resources
Full Text Sources